In 54 GC patients who underwent preoperative chemotherapy (group A), high SPARC expression after chemotherapy correlated with depth of invasion, lymph node metastasis, and TNM stage (P<0.05) (Table 2). The gene discussed is SPARC; the disease is gastric cancer.